Message from the President
Dear Members of the American Contact Dermatitis Society,
Our Society is really moving! There is so much news to
share, but I want to start with a THANK YOU to Dr. Andrew Scheman for
his years of service to the Society as Director of our Contact Allergen
Management Program (CAMP). Dr. Scheman resigned as CAMP Director in May
2019 and we will miss him in this role. Dr. Scheman’s dedication to the
Society has been nothing short of fantastic! We all owe so much of our
patch test success to his efforts over the years. If you see him please
be sure to extend a thank you for his years of service!
Dr. Margo Reeder and Dr. JiaDe (Jeff) Yu will serve as
Interim CAMP Co-Directors until September 1, 2019. Please feel free to
submit your CAMP questions and suggestions directly to our Co-Directors
through the CAMP Suggestion Box. In addition, you may have noticed our
advertisement for our new CAMP Director. If you are interested, you may submit your application. Applications are due July 5, 2019.
Our volunteers are incredibly dedicated to the Society! The
ACDS Board of Directors recently came together to discuss, develop and
implement a vision and strategic plan which confirms the American
Contact Dermatitis Society’s commitment to advancing the care and
understanding of dermatitis and allergy. I am excited and honored to
share our new ACDS Vision and Mission Statement and overall strategic
focus for 2019-2021.
The American Contact Dermatitis Society is committed to
advancing the care and understanding of dermatitis and allergy.
The mission of the American Contact Dermatitis Society is to
be the premier organization cultivating advancements in the diagnosis
and care of dermatitis through the promotion of education, research, and
advocacy. Our society is dedicated to understanding, and investigating
the interplay among contact, occupational, atopic, photo, drug and other
forms of dermatitis.
To achieve and implement the new Vision and Mission
Statements, our Society leaders assembled a 2019-2021 Strategic Plan,
outlining the upcoming goals and focus for ACDS. The specific goals and
objectives identified within the 2019-2021 Strategic Plan include:
- Infrastructure and Organizational Development: Ensure adequate resources for the vitality and long-term sustainability of the organization.
- Membership Engagement and Growth: Increase, enhance, and diversify an engaged membership.
- Contact Allergen Management Program (CAMP): Expand CAMP’s capabilities and educational resources to allow for an improved physician and patient experience.
I look forward to achieving the goals put forth by our
membership and will do my best as ACDS President to continue to strive
for success in the upcoming months. If you have any questions or
feedback regarding the outlook for the Society, please feel free to
reach out by emailing the ACDS National Office at firstname.lastname@example.org.
Yours in Patch Testing,
Inside this Issue
Fisher Lecturer Announcement!
We are excited to announce D. Linn Holness, MD,
as the American Contact Dermatitis Society’s 2020 Fisher Lecture
honoree! Dr. Holness is from the Centre for Research Expertise in
Occupational Disease, University of Toronto, and St. Michael's Hospital,
is the author of over 100 articles and teaches researchers and
She has been a significant contributor to the understanding of
occupational skin disease including patch testing methodology and
epidemiological studies, epidemiological studies of exposed populations,
development of standardized data collection instruments, and outcomes
and health services utilization. She is also interested in the
interaction between lung and skin disease, including the atopic march.
She is devoted to returning patients to the workplace, and is especially
interested in marginalized populations such as those in inner city
workplaces. She is a systems thinker and has studied occupational health
service delivery models. Our society benefits from the interaction of
dermatologist, allergists, and occupational medicine physicians.
Please join us to hear Dr. Holness’s presentation and to honor her work at our 2020 ACDS Annual Meeting!
The 31st Annual Meeting of the ACDS will be held on Thursday,
March 19, 2020, at The Grand Hyatt Denver in Denver, CO. Registration
will open in Fall, 2019. Follow #ACDS20 for the latest updates.
Susan Nedorost, MD
Chair, ACDS Fisher Award & Fisher Lectureship Committee
Congratulations to our Grant Winners!
The American Contact Dermatitis Society is committed to advancing
the care and understanding of dermatitis and allergy through the
promotion of education, research, and advocacy. As part of this
initiative, ACDS offers the following educational awards to help
encourage research in these areas.
Congratulations to Dr. Jennifer Powers who has been awarded the ACDS Mid-Career Development Award!
The ACDS Mid-Career Development Award provides financial support
for ACDS members to defray the cost of acquiring specific skills and
knowledge to enhance their professional development in some aspect of
contact dermatitis and/or occupational dermatology.
Congratulations to Dr. Kathryn Somers and Dr. Brandon Adler who have been awarded the ACDS Mentoring Award.
The ACDS Mentoring Award is granted for the purpose of assisting
young dermatologists including dermatology residents, dermatology
fellows, or dermatologist up to 5 years out of residency to become
leaders/experts in the field of contact dermatitis by acquiring
additional academic skills which may not be available at their training
Clinical Research Award
Congratulations to Dr. JiaDe (Jeff) Yu who has been awarded the ACDS Clinical Research Award.
The ACDS Clinical Research Award is granted for the purpose of
relevant clinical studies directed toward the subject of contact
dermatitis. Studies which focus on clinical problems or have
applications to clinical problems will receive preferential
Interested in applying? Find out more information about the below ACDS educational award opportunities.
Application deadline is October 15, 2019.
Exciting Changes Ahead for CAMP!
It is with great excitement that ACDS announces that CAMP will
undergo a transformation to significantly improve the physician and
patient experience within the next year. We recognize that CAMP is a
vital tool for our members and patients in the management of allergic
contact dermatitis. We are excited about this opportunity to
dramatically improve on the functionality that CAMP provides both you
and your patients. A small sampling of improvements to come include:
- Substantially increased number of products within the database
- A new and more user-friendly web interface
- Educational materials and handouts to assist in allergen counseling
As part of this process, ACDS will be onboarding a CAMP Director
to oversee this process and is putting out a call for applications.
Applications will be accepted through July 5th. Please see below for more information and the application process.
Friday, July 5, 2019 at 11:59pm CST
For a complete job description and more information, please click here.
ACDS Mid-Year Meeting - September, 2020!
ACDS will hold a Mid-Year Meeting September 25-26, 2020 in
Philadelphia. Save the date and follow #ACDSMID20 for the latest
ACDS Member Highlight
Congratulations to Dr. Erin Warshaw, who will be
giving the Prosser-White Oration at the British Association of
Dermatologists/British Society for Cutaneous Allergy Annual Meeting in
July 2019. Dr. Warshaw will be speaking on acrylates and new and
For more information, please visit the British Association of Dermatologists Annual Meeting Website.
ACDS AMA and Health Policy Committee Update
Update from the AMA
The American Contact Dermatitis Society (ACDS) was well
represented at the recent AMA Annual Meeting held in Chicago in June
2019. Our AMA Representative to the AMA Specialty and Service Society,
Bruce A. Brod, MD, FAAD, testified before an AMA Reference Committee on
behalf of a resolution pertaining to Medicare Part D Plans sharing
excess revenue with patients and on a resolution supporting the
viability of drug importation as a workaround to high drug costs and
The ACDS is a member of the Dermatology Section Council (DSC) and
at this recent meeting there was intense collaboration with the allergy
caucus on a resolution opposing pharmacy board oversight of physician
preparation of buffered lidocaine in the office. The DSC sponsored
resolution supporting advocacy for shade structures was adopted by the
AMA House of Delegates and a resolution, which the ACDS actively
supported, calling on advocacy to support prescription only use of
vaping was adopted. Vaping has been linked to possible airborne contact
dermatitis. A comprehensive policy on how to approach Augmented
Intelligence was adopted by the AMA House of Delegates (HOD).
The ACDS continues to progress to full voting status in the AMA
HOD. ACDS is on track to become a full voting member in the HOD by
Appeal Limits on Reimbursement for Patch Testing
ACDS in collaboration with the American Academy of Dermatology
Association has filed an appeal to reverse the limits on patch testing
to 80 allergens by date of service. This change resulted from a change
in the use of medically unlikely edits (MUE) from a line edit to a date
of service edit. We will continue to keep our members updated on the
decision from the National Correct Coding Initiative (NCCI).
Bruce A. Brod, MD
Chair, ACDS AMA and Health Policy Committee
ACDS has gone SOCIAL!
ACDS is officially live on Twitter, Facebook, and Instagram! We
will use these mediums to disseminate important information to the
public, connect with our members, and to promote the important work ACDS
members are doing. Please add or follow ACDS.
If you have thoughts or questions regarding our new social networks, please email them to Dr. JiaDe (Jeff) Yu at JDYU@partners.org,
the Chair of the Social Media/Interactive Media Committee. We welcome
any and all ideas including your publications, your talks, and any
important information you wish to disseminate.